Bioclinica, a leading provider of technology-enabled clinical trial solutions, announced safety software company AB Cube has joined its eHealth App xChange™, an alliance channel within the eHealth Solutions business segment to advance technology innovation across life sciences and healthcare. Under the partnership, AB Cube’s comprehensive, cloud-based pharmacovigilance platform for management of adverse events will become part of Bioclinica’s extensive eHealth App xChange offerings available in the Bioclinica eHealth Cloud™.
“Our eHealth Solutions team is collaborating with highly innovative technology partners around the globe, and in AB Cube we foresee an industry transformation toward a next-generation safety platform that brings simplicity, proven savings and efficiencies with a unique cloud architecture and advanced process automation capabilities,” said Bioclinica President eHealth Solutions Mukhtar Ahmed.
Paris-based AB Cube’s safety technology, already selected by more than 300 companies worldwide as their safety platform of choice, has the flexibility to handle any volume of case processing, large or small.
Pharmacovigilance, crucial to an effective drug regulation system and clinical research, is focused on evaluating and monitoring adverse drug reactions and minimizing the risk of harm to patients. The Bioclinica-AB Cube collaboration brings a cloud safety platform along with process automation capabilities to simplify the pharmacovigilance process and maintain compliance with strict worldwide laws, regulations and guidance.
“We are delighted to partner with Bioclinica on a safety solution that aligns so well with their technology-agnostic philosophy,” said AB Cube CEO Matthieu Doresse. “As a true SaaS offering where everyone uses the same version and is informed well in advance of automatic system updates, the platform is a huge leap forward in terms of ease of implementation and maintenance as well as decreased total cost of ownership.”